Rowan Arida | Neuropharmacology | Best Researcher Award

Published on by Technology Scientists

Best Researcher Award

                    Rowan Arida
Affiliation Alamein International University
Country Egypt
Scopus ID 60155542600
Documents 3
Citations 1
h-index 1
Subject Area Neuropharmacology
Event Technology Scientists Awards
ORCID 0009-0006-4740-1380

Rowan Arida of Alamein International University, Egypt, is recognized through the Technology Scientists Awards for scholarly contributions to neuropharmacology. Her published research investigates mechanisms of neuroinflammation, organophosphate toxicity, mitochondrial dysfunction, metabolic impairment, and therapeutic strategies for neurodegenerative disorders. The award acknowledges the scientific relevance, emerging research profile, and growing contribution reflected through peer-reviewed publications and recognized scholarly databases.[1]

Abstract

Rowan Arida has established an emerging academic profile in neuropharmacology through investigations of organophosphate-induced neurotoxicity, mitochondrial dysfunction, neuroinflammation, metabolic impairment, and therapeutic strategies for neurodegenerative diseases. Her publications combine molecular biology, proteomics, and pharmacological approaches to understand neuronal injury and identify potential interventions. The research demonstrates interdisciplinary collaboration while addressing biomedical challenges associated with environmental toxicology and neurological disorders. Recognition through the Technology Scientists Awards reflects the quality, scientific relevance, and future promise of these peer-reviewed contributions within modern neuroscience and pharmacological research communities.[1][2][3]

Keywords

Neuropharmacology, Neuroinflammation, Organophosphate Toxicity, Endocannabinoid System, Mitochondrial Dysfunction, Proteomics, LC-MS/MS, Neurodegenerative Diseases, Metabolic Impairment, Synaptic Dysfunction, Therapeutic Targets, Biomedical Research.

Introduction

Rowan Arida conducts research focused on neuropharmacology, emphasizing mechanisms underlying neurotoxicity, inflammation, and metabolic dysfunction. Her investigations integrate experimental pharmacology with molecular analysis to improve understanding of neurological disorders and potential therapeutic interventions while contributing to contemporary biomedical knowledge through peer-reviewed scientific publications.[1]

Research Profile

Affiliated with Alamein International University, Rowan Arida has developed a focused publication portfolio addressing neuropharmacology and toxicological neuroscience. Her scholarly profile includes Scopus-indexed research exploring molecular mechanisms of neuronal injury, proteomic analysis, and regulated cell death pathways relevant to neurological disease progression.[2]

Research Contributions

Her research contributes evidence linking organophosphate exposure with neuroinflammation, mitochondrial dysfunction, synaptic impairment, and metabolic abnormalities. These findings advance understanding of disease mechanisms while supporting investigation of therapeutic targets capable of reducing neuronal damage and improving outcomes in neurodegenerative disorders.[1][3]

Publications

Published studies examine endocannabinoid system perturbation, hippocampal mitochondrial dysfunction, proteomic biomarkers, and therapeutic approaches targeting regulated cell death. Collectively, these articles demonstrate consistent engagement with neuroscience, molecular pharmacology, and translational biomedical research addressing significant neurological and metabolic health challenges.[1][2][3]

Research Impact

Although representing an early-stage publication record, the research provides valuable mechanistic insights supporting future investigations into neurodegenerative diseases and environmental toxicology. The interdisciplinary methodology enhances scientific relevance and establishes a foundation for continued collaboration, innovation, and evidence-based therapeutic development.[2]

Award Suitability

Recognition through the Best Researcher Award appropriately acknowledges Rowan Arida’s contributions to neuropharmacology, emphasizing scientific rigor, interdisciplinary investigation, and promising research addressing neurological disorders. The published work demonstrates commitment to advancing biomedical understanding while supporting future innovation within neuroscience and pharmacological sciences.[3]

Conclusion

Rowan Arida’s scholarly activities reflect focused investigation into neuropharmacological mechanisms associated with neurotoxicity and neurodegeneration. Through peer-reviewed publications and interdisciplinary methodologies, her research contributes meaningful scientific knowledge while demonstrating continued potential for advancing biomedical science, therapeutic discovery, and translational neuroscience research.[1][3]

References

  1. Arida, R., et al. (2025). Role of Endocannabinoid System Perturbation in Organophosphate-Mediated Metabolic Impairment and Neuroinflammation. Scopus Indexed Publication.
    https://www.scopus.com/pages/publications/105029756599
  2. Arida, R., et al. (2025). Hippocampal Mitochondrial Dysfunction and Synaptic Disruption Link Organophosphate Exposure to Pre-Diabetes: An LC-MS/MS-Based Proteomics Approach. Biomolecules, 16(7), 952.
    https://www.mdpi.com/2218-273X/16/7/952
  3. Arida, R., et al. (2025). Therapeutic Approaches Targeting Regulated Cell Death in Neurodegenerative Diseases: Current Understanding and Recent Advances in Combating Neuronal Loss. Scopus Indexed Publication.
    https://www.scopus.com/pages/publications/105019730290

Tamanna Yasmin | Neuroscience | Tech Advancement Award

Published on by Technology Scientists

Ms. Tamanna Yasmin | Neuroscience | Tech Advancement Award

Ph.D Researcher | Korea Institute of Science and Technology | South Korea

Ms. Tamanna Yasmin, affiliated with the Korea Institute of Science and Technology, conducts interdisciplinary research at the interface of neurobiology, metabolism, and natural-product pharmacology. Her work focuses on understanding how metabolic modulation affects neuronal excitability and energy homeostasis, with particular emphasis on obesity and metabolic disorders. She has demonstrated the therapeutic potential of bioactive compounds, such as gintonin from Korean red ginseng, in preclinical models, bridging natural-product research with neuroscience and metabolic disease. To date, she has authored 3 peer-reviewed publications, which have collectively received 67 citations and contributed to an h-index of 1, reflecting a growing impact within the scientific community. Collaborating across disciplines including pharmacology, nutrition, and biomedical sciences, she advances both fundamental knowledge and translational approaches for metabolic and neurophysiological health. Her work holds promise for developing innovative, physiology-based interventions that address global challenges in metabolic disorders, obesity, and brain-body health.

Profiles: Scopus | ORCID | Google Scholar

Featured Publications

1. Nam, Y. H., Hong, B. N., Rodriguez, I., Park, M. S., Jeong, S. Y., Lee, Y.-G., Shim, J. H., Yasmin, T., Kim, N. W., Koo, Y. T., Lee, S. H., Paik, D.-H., Jeong, Y. J., Jeon, H., Kang, S. C., Baek, N.-I., & Kang, T. H. (2020). Steamed Ginger May Enhance Insulin Secretion through KATP Channel Closure in Pancreatic β-Cells Potentially by Increasing 1-Dehydro-6-Gingerdione Content. Nutrients, 12(2), 324. https://doi.org/10.3390/nu12020324 MDPI+1

Cited by: 40

2. Nuankaew, W., Heemman, A., Wattanapiromsakul, C., & colleagues. (2021). Anti-insulin resistance effect of constituents from Senna siamea on zebrafish model, its molecular docking, and structure–activity relationships. Journal of Natural Medicines, 75(3), 520–531. https://doi.org/10.1007/s11418-021-01490-5 SpringerLink+1

Cited by: 16

3. Park, S., Jeong, S. Y., Nam, Y. H., Park, J. H., Rodriguez, I., Shim, J. H., Yasmin, T., Kwak, H. J., Oh, Y., Oh, M., & colleagues. (2021). Fatty Acid Derivatives Isolated from the Oil of Persea americana (Avocado) Protects against Neomycin-Induced Hair Cell Damage. Plants, 10(1), 171. https://doi.org/10.3390/plants10010171 MDPI+1

Cited by: 11

4. Yasmin, T., Lee, Y., Kim, W. S., Lee, B., R. Lee, H. Hwang, M. H. Nam, S. Y. Nah, & colleagues. (2025). Lipid-Enriched Gintonin from Korean Red Ginseng Marc Alleviates Obesity via Oral and Central Administration in Diet-Induced Obese Mice. Nutrients, 17(23), 3794.

5. Yasmin, T., Lee, Y., Hwang, H., Seo, J., Kim, M. S., Park, M., Oh, S.-J., Nam, M.-H., & Rhim, H. (2025). Elevated O-GlcNAcylation Enhances Metabolic Rate and Reduces the Excitability of Hypothalamic ARC Neurons in 10-month-old Male Mice. Experimental Neurobiology, 34(4), 147–155. https://doi.org/10.5607/en25012 PMC+2KIST Pubs+2

Ms. Tamanna Yasmin’s research integrates natural-product pharmacology with neuro-metabolic science, aiming to develop novel, physiologically grounded interventions for metabolic disorders and obesity, contributing to global health, biomedical innovation, and translational neuroscience.